 At baseline and year 2 of the trial, approximately 500 participants living within driving distance of Boston, Massachusetts will provide additional measurements from in-clinic study visits at the Clinical and Translational Science Center CTSC of Brigham and Womens Hospital. These visits will include cognitive function assessments, anthropometrics, physical function assessments, blood pressure and other measurements. 